Home
|
Show All
|
Simple Search
|
Advanced Search
Login Admin Infodrog
Quick Search:
Field:
main fields
author
title
publication
year
keywords
publisher
call_number
notes
contains:
1–1 of 1 record found matching your query (
RSS
):
Search & Display Options
Search within Results:
Field:
author
title
year
keywords
abstract
type
publication
abbrev_journal
volume
issue
pages
thesis
publisher
place
editor
series_title
language
area
notes
call_number
serial
contains:
Exclude matches
Display Options:
Style:
APA
AMA
MLA
Chicago
Harvard 1
Harvard 2
Harvard 3
Vancouver
Deep Sea Res
J Glaciol
Mar Biol
Text Citation
Sort by:
(custom)
author
year
type
type, year
date created
per page
Select All
Deselect All
<<
1
>>
List View
|
Citations
|
Details
Bousingen, D. D. de. (2001). Drug firm compensates patients for suspected hepatitis B vaccine failure.
The Lancet
,
357
(19.05.2001), 1598.
Abstract:
A French appeal court has ordered GlaxoSmithKline (GSK) to pay US$6686 and US$10 697 in compensation to two women with multiple sclerosis who claim the chronic disease was caused by a hepatitis B vaccine (Engerix B) manufactured by the pharmaceutical company.
Keywords:
health promotion; viral hepatitis; hepatitis B
Permanent link
| Save citation:
RTF
PDF
LaTeX
| Export record:
BibTeX
Endnote
ISI
RIS
Atom XML
MODS XML
ODF XML
Word XML
Select All
Deselect All
<<
1
>>
List View
|
Citations
|
Details
Home
Show Record
|
Extract Citations
